Potential new MS drug could regenerate myelin



A study finds that blocking the M3R receptor improves myelination in mice implanted with human progenitor cells, maybe leading to clinical trials in MS.



Source link

Be the first to comment

Leave a Reply

Your email address will not be published.


*